The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: Comparison with their normal cellular counterparts

Gale, 1985, Chronic lymphocytic leukemia: Recent advances in biology and treatment, Ann. Intern. Med., 103, 101, 10.7326/0003-4819-103-1-101 Hayakawa, 1988, Normal, autoimmune and malignant CD5+ B cells: The Ly-1 B lineage?, Immun. Rev., 6, 197, 10.1146/annurev.iy.06.040188.001213 Caligaris-Cappio, 1982, Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia, J. expl Med., 155, 623, 10.1084/jem.155.2.623 Hardy, 1987, Rheumatoid factor secretion from human LEU-1+ B cells, Science, 236, 81, 10.1126/science.3105057 Antin, 1986, LEU-1+ (CD5+) B cells, 136, 505 Caligaris-Cappio, 1989, Human normal CD5+ B lymphocytes can be induced to differentiate to CD5− B lymphocytes with germinal center cell features, Blood, 73, 1259, 10.1182/blood.V73.5.1259.1259 Freedman, 1989, Studies of in vitro activated CD5+ B cells, Blood, 73, 202, 10.1182/blood.V73.1.202.202 Freedman, 1987, Normal cellular counterparts of B cell chronic lymphocytic leukemia, Blood, 70, 418, 10.1182/blood.V70.2.418.418 Kipps, 1987, Genetic influence on the levels of circulating CD5 B lymphocytes, J. Immun., 139, 1060 Freedman, 1989, Expression and regulation of CD5 on in vitro activated human B cells, Eur. J. Immun., 19, 849, 10.1002/eji.1830190511 Defrance, 1989, Human interleukin-4 down-regulates the surface expression of CD5 on normal and leukemic B cells, Eur. J. Immun., 19, 293, 10.1002/eji.1830190212 Sarfati, 1988, Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia, Blood, 71, 94, 10.1182/blood.V71.1.94.94 Sarfati, 1990, Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia, Leukemia Res., 14, 47, 10.1016/0145-2126(90)90145-Y Swendeman, 1987, The activation antigen BLAST-2 when shed, is an autocrine BCGF for normal and transformed B cells, EMBO J., 6, 1637, 10.1002/j.1460-2075.1987.tb02412.x Gordon, 1989, CD23: a multi-functional receptor/lymphokine?, Immun. Today, 10, 153, 10.1016/0167-5699(89)90171-0 Delespesse, 1989, Human IgE-binding factors, Immun. Today, 10, 159, 10.1016/0167-5699(89)90173-4 Yokota, 1988, Two species of human Fcε receptor II (FcεRII/CD23): Tissue-specific and IL4-specific regulation of gene expression, Cell, 55, 611, 10.1016/0092-8674(88)90219-X Rai, 1975, Clinical staging of chronic lymphocytic leukemia, Blood, 46, 219, 10.1182/blood.V46.2.219.219 Sarfati, 1986, Presence of antigenic determinants common to Fc IgE receptors on human macrophages, T and B lymphocytes and IgE-binding factors, Immunology, 59, 569 Ludin, 1987, Cloning and expression of the cDNA coding for human lymphocyte IgE receptor, EMBO J., 6, 109, 10.1002/j.1460-2075.1987.tb04726.x Frohman, 1988, Rapid production of full-length cdNAS from rare transcripts: amplification using a single gene-specific oligonucleotide primer, PNAS, 85, 8998, 10.1073/pnas.85.23.8998 Nakajima, 1987, Relationship between human IgE-binding factors and lymphocyte receptors for IgE, J. Immun., 139, 848 Ishida, 1989, Heterogeneity in terms of interleukin 4-dependent regulation of Fcε receptor/CD23 expression on chronic B-lymphocytic leukemia cells, Immun. Letters, 20, 323, 10.1016/0165-2478(89)90042-4 Dadmarz, 1988, Heterogeneity of CLL: High CD23 antigen and IFN receptor expression are features of favourable disease and of cell activation, Br. J. Haemat., 68, 279, 10.1111/j.1365-2141.1988.tb04203.x Digel, 1983, Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia, Blood, 73, 1242, 10.1182/blood.V73.5.1242.1242 Defrance, 1987, Human recombinant interleukin 4 induces Fcε receptors (CD23) on normal human B lymphocytes, J. expl Med., 165, 1459, 10.1084/jem.165.6.1459 Vercelli, 1988, Recombinant human interleukin 4 induces FcεR2/CD23 on normal human monocytes, J. expl Med., 167, 1406, 10.1084/jem.167.4.1406 Chrétien, 1990, Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-γ, Eur. J. Immun., 20, 243, 10.1002/eji.1830200203 Spiegelberg, 1979, Lymphocytes with immunoglobulin E Fc receptors in patients with atopic disorders, J. clin. Invest., 64, 714, 10.1172/JCI109514 Hivroz, 1989, Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4, Eur. J. Immun., 19, 1025, 10.1002/eji.1830190611 Keegan, 1989, Superinduction of the murine B cell FcεRII by T helper cell clones, J. Immun., 142, 3868 Karray, 1988, Interleukin-4 counteracts the interleukin 2-induced proliferation of monoclonal B cells, J. expl Med., 168, 85, 10.1084/jem.168.1.85 Luo, 1991, IL4 displays potent in vitro anti-proliferative activity in B chronic lymphocytic leukemia, J. Immunother. Lebrun, 1988, IgE formation and Fc receptor positive lymphocytes in normal, immuno-deficient, and auto-immune mice infected with Nippostrongylus Brasiliensis, J. Immun., 141, 249 Durandy, 1990, Phenotypic and functional characteristics of human newborns B lymphocytes, J. Immun., 144, 60 Peleman, 1990, In vitro synthesis of human IgE by neonatal lymphocytes: enhancing effect of IFN-γ, Cell Immun., 129, 299, 10.1016/0008-8749(90)90206-7 Sarfati, 1989, IgE synthesis by chronic lymphocytic leukemia cells, J. expl Med., 170, 305, 10.1084/jem.170.5.1775 Mossalayi, 1989, Soluble CD23 (FcεRII) and interleukin 1 synergistically induce early human thymocyte maturation, J. expl Med., 171, 959, 10.1084/jem.171.3.959 Mossalayi, 1990, Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23, Blood, 75, 1924, 10.1182/blood.V75.10.1924.1924